Concert Pharma names development head
This article was originally published in Scrip
Executive Summary
Concert Pharmaceuticals has appointed Dr James V Cassella chief development officer. In the newly created role, Dr Cassella will lead Concert's product development strategy and operations and will have responsibility for all preclinical, clinical and manufacturing activities. Most recently, Dr Cassella was executive vice-president of R&D and chief scientific officer of Alexza Pharmaceuticals.